Suppr超能文献

鱼类的抗癌作用

Anticarcinogenesis in fish.

作者信息

Bailey G, Hendricks J, Dashwood R

机构信息

Oregon State University, Corvallis 97331.

出版信息

Mutat Res. 1992 Jun;267(2):243-50. doi: 10.1016/0027-5107(92)90068-d.

Abstract

Rainbow trout respond to a range of natural and synthetic dietary tumor modulators. Observed modulations of final tumor incidence include inhibition, promotion and cocarcinogenesis, depending on modulator, carcinogen, target organ, and relative order of carcinogen and modulator exposure. Despite several obvious limitations (e.g. lung, colon, mammary gland, bladder are not available as target organs), the trout model possesses several important features that have made it valuable for tumor modulation studies. (1) The comparative advantage. Since rodents are not perfect human surrogates, studies with alternative vertebrates such as trout have provided important comparative mechanism information for confident extrapolation of animal studies to humans. For example, beta-naphthoflavone appears to inhibit aflatoxin B1 hepatocarcinogenicity by species-independent mechanisms that readily extrapolate to humans. By contrast other modulators, including butylated hydroxyanisole, inhibit aflatoxin B1 hepatocarcinogenesis in rats by an enabling mechanism shown to be absent in trout, namely the induction of an aflatoxin B1-specific glutathione S-transferase isozyme. Interestingly, evidence is presently lacking that this determinant mechanism would be operative in humans. (2) The sensitivity advantage. Trout sensitivity and small body size at exposure have permitted tumor studies with carcinogens and HPLC-purified anticarcinogen intermediates too scarce to study in rodents. (3) The low cost advantage. The very low cost of trout tumor studies has enabled statistically challenging issues in molecular dosimetry, dose-response, and risk-benefit analysis to be addressed using as many as 9600 animals per tumor study at modest budget. In particular, these designs provide modulator-mediated alterations in precisely determined carcinogen TD50 values, rather than changes in simple tumor incidence, to quantify more rigorously modulator potencies for tumor inhibition or promotion as a function of dietary concentrations.

摘要

虹鳟鱼对一系列天然和合成的膳食肿瘤调节剂有反应。观察到的最终肿瘤发生率的调节包括抑制、促进和协同致癌作用,这取决于调节剂、致癌物、靶器官以及致癌物和调节剂暴露的相对顺序。尽管存在一些明显的局限性(例如,肺、结肠、乳腺、膀胱不能作为靶器官),但虹鳟鱼模型具有几个重要特征,使其在肿瘤调节研究中具有重要价值。(1)比较优势。由于啮齿动物并非完美的人类替代物,对虹鳟鱼等其他脊椎动物的研究提供了重要的比较机制信息,有助于将动物研究可靠地外推至人类。例如,β-萘黄酮似乎通过易于外推至人类的物种非依赖性机制抑制黄曲霉毒素B1的肝癌致癌性。相比之下,其他调节剂,包括丁基羟基茴香醚,通过一种在虹鳟鱼中不存在的促成机制抑制大鼠体内黄曲霉毒素B1的肝癌发生,即诱导一种黄曲霉毒素B1特异性谷胱甘肽S-转移酶同工酶。有趣的是,目前缺乏证据表明这种决定性机制在人类中起作用。(2)敏感性优势。虹鳟鱼在暴露时的敏感性和较小的体型使得能够对致癌物和经高效液相色谱纯化的抗癌剂中间体进行肿瘤研究,而这些物质在啮齿动物中因过于稀少而无法研究。(3)低成本优势。虹鳟鱼肿瘤研究的成本非常低,这使得在适度预算下,每个肿瘤研究使用多达9600只动物来解决分子剂量学、剂量反应和风险效益分析中具有统计学挑战性的问题成为可能。特别是,这些设计提供了调节剂介导的精确确定的致癌物半数致死剂量(TD50)值的改变,而不是简单的肿瘤发生率变化,以便更严格地量化作为膳食浓度函数的调节剂对肿瘤抑制或促进的效力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验